A new study finds that men with prostate cancer that has spread to nearby lymph nodes, who have a significant risk of dying from the disease, can benefit from the addition of radiation therapy to treatments that block the effects of testosterone.
The findings imply that the almost half of patients with node-positive disease nationwide who this study found had not received combination therapy were not receiving the treatment that could best control their tumour and possibly save their lives. The report from investigators at the Massachusetts General Hospital (MGH) Cancer Center and the American Cancer Society has been published online in the Journal of the National Cancer Institute.
